Corundum Trust Company’s Amgen AMGN Stock Holding History

Corundum Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40	Closed	-$11.3K	–	55
2025 Q3	$11.3K	Buy	+40	New	+$11.6K	0.02%	121

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Corundum Trust Company's AMGN Position: Q4 2025 in Review

Corundum Trust Company sold out of Amgen (AMGN) in Q4 2025, closing a stake of 40 shares — an estimated $11.3K sold.

Corundum Trust Company first reported a position in AMGN in Q3 2025 and held it in 1 quarter. The position peaked at $11.3K in Q3 2025. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

Corundum Trust Company reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 40 Amgen shares in Q4 2025, an estimated $11.3K.
Corundum Trust Company first reported a position in Amgen in Q3 2025 and held it in 1 quarter.
Corundum Trust Company's Amgen position peaked at $11.3K in Q3 2025.
3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.